GlassScriptPhysician profile
Christopher P Volturo
NPI 1346522687
$1,925.93
in general payments reported to CMS, 2019-2025
25 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $381 · 2024: $409 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,826.93 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $287.59 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $282.18 | 2023-2025 | |
| Abbvie INC. | $256.04 | 2023-2025 | |
| Lilly USA, LLC | $160.81 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $144.73 | 2025 | Veozah |
| Axsome Therapeutics, INC. | $124.30 | 2023-2025 | Auvelity, Symbravo |
| Glaxosmithkline, LLC. | $93.65 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $72.33 | 2024-2025 | Airsupra, Breztri |
| Ars Pharmaceuticals Operations, INC. | $61.70 | 2025 | Neffy |
| Exact Sciences Corporation | $48.68 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Theratechnologies INC. | $45.13 | 2023-2025 | Egrifta, Trogarzo |
| Philips North America LLC | $40.76 | 2025 | Mcot |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.54 | 2023-2025 | Xifaxan, Trulance |
| Tris Pharma INC | $35.33 | 2023-2025 | Dyanavel Xr |
| Amgen INC. | $34.81 | 2023-2024 | Prolia, Evenity |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $30.65 | 2023 | |
| Medtronic, INC. | $28.69 | 2025 | Minimed 780g |
| Viiv Healthcare Company | $25.39 | 2023 | Rukobia |
| Dexcom, INC. | $23.30 | 2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.06 | 2025 | Jardiance |
| Neos Therapeutics, LP | $17.62 | 2023 | Adzenys Xr-Odt |
| Merck Sharp & Dohme LLC | $15.18 | 2024 | Gardasil 9, Gardasil |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.60 | 2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $14.39 | 2023 | |
| Neuronetics, INC. | $10.47 | 2025 | Neurostar Tms Therapy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Volturo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.